Positron Emitting Activity [MoA] - N0000175869

Pharmacologic Class Information

Pharmacologic Code N0000175869
Pharmacologic Name Positron Emitting Activity
Pharmacologic Uses
  • radioactive diagnostic agent
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Positron Emitting Activity

The following table contains 8 products whose active ingredient are classified under the same pharmacologic class Positron Emitting Activity [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0002-1200Amyvid Non-Proprietary Name: Florbetapir F 18Injection, SolutionIntravenousEli Lilly And CompanyACTIVE
24275-0525Gallium Ga-68 Psma-11 Non-Proprietary Name: Gallium Ga-68 GozetotideInjection, SolutionIntravenousUcsf Radiopharmaceutical FacilityACTIVE
54828-001Neuraceq Non-Proprietary Name: Florbetaben F 18Injection, SolutionIntravenousLife Molecular Imaging, LtdACTIVE
69932-001Axumin Non-Proprietary Name: Fluciclovine F-18Injection, SolutionIntravenousBlue Earth DiagnosticsACTIVE
69945-064Detectnet Non-Proprietary Name: Copper Cu 64 DotatateInjection, SolutionIntravenousCurium Us LlcACTIVE
71258-022Pylarify Non-Proprietary Name: Piflufolastat F-18InjectionIntravenousProgenics Pharmaceuticals, Inc.ACTIVE
72874-001Cerianna Non-Proprietary Name: Fluoroestradiol F 18InjectionIntravenousZionexa Us CorporationACTIVE
76394-2642Gallium Ga-68 Psma-11 Non-Proprietary Name: Gallium Ga-68 GozetotideInjection, SolutionIntravenousUcla Biomedical CyclotronACTIVE